Surviving Sepsis Campaign

Surviving Sepsis Campaign
Name	Surviving Sepsis Campaign
Formation	2002
Type	Medical guideline initiative
Headquarters	International
Region served	Global

Surviving Sepsis Campaign The Surviving Sepsis Campaign is an international initiative to improve recognition, management, and outcomes of sepsis through clinical guidelines, education, and quality improvement programs. Founded through collaboration among major professional bodies and philanthropic organizations, the Campaign issues evidence-based recommendations and promotes implementation strategies in hospitals, health systems, and global health programs. The initiative interacts with professional societies, governmental agencies, and research consortia to influence critical care practice internationally.

Overview

The Campaign brings together stakeholders such as Society of Critical Care Medicine, European Society of Intensive Care Medicine, World Health Organization, National Institutes of Health, and Centers for Disease Control and Prevention to create coordinated efforts for sepsis care, engaging clinicians from American College of Chest Physicians, Royal College of Physicians, American Thoracic Society, Infectious Diseases Society of America, and International Sepsis Forum. It targets clinicians in settings influenced by institutions like Mayo Clinic, Cleveland Clinic, Johns Hopkins Hospital, Massachusetts General Hospital, and Guy's and St Thomas' NHS Foundation Trust while aligning with research networks such as ClinicalTrials.gov, European Medicines Agency, Wellcome Trust, Bill & Melinda Gates Foundation, and National Health Service initiatives.

Guideline Development and Recommendations

Guideline panels include experts affiliated with organizations like American College of Emergency Physicians, Royal College of Emergency Medicine, Australian and New Zealand Intensive Care Society, Japanese Society of Intensive Care Medicine, and Canadian Critical Care Trials Group, drawing on evidence from trials registered with ISRCTN, Coordinating Center for Health Research, and reviews by Cochrane Collaboration. Recommendations cover diagnostics, resuscitation, antimicrobial therapy, and organ support, referencing modalities developed or evaluated at centers such as Stanford Health Care, Karolinska University Hospital, Imperial College London, University of Toronto, and Severn Trent, and informed by regulators like Food and Drug Administration and European Commission. Panels have debated therapy elements studied in trials associated with PROWESS, SOAP, VANISH, ARISE, and PROCESS, producing graded guidance on interventions used in settings including Intensive Care Unit, Emergency Department, and Neonatal Intensive Care Unit at institutions like Great Ormond Street Hospital and Royal Children's Hospital.

Implementation and Quality Improvement

Implementation strategies promote bundles, pathways, and audit cycles used by health systems such as Kaiser Permanente, Veterans Health Administration, NHS England, Ontario Health, and Fondazione Policlinico Gemelli to monitor compliance, outcomes, and cost metrics. Quality initiatives are integrated with registries and performance programs like National Surgical Quality Improvement Program, Australian and New Zealand Intensive Care Society Adult Patient Database, EuroQol Group, Premier Healthcare Database, and Get With The Guidelines to facilitate benchmarking across hospitals including UCLA Medical Center, Karolinska University Hospital, and Mount Sinai Health System. Educational outreach partners include World Federation of Societies of Anaesthesiologists, Royal College of Nursing, European Respiratory Society, American Association of Critical-Care Nurses, and Global Sepsis Alliance.

Controversies and Criticisms

Critiques have come from academics at institutions such as University College London, University of Oxford, Harvard Medical School, Yale School of Medicine, and University of Pittsburgh School of Medicine who questioned aspects of evidence grading, bundle rigidness, and resource implications. Debates referenced trials and analyses from groups associated with NEJM, The Lancet, JAMA, BMJ, and Annals of Internal Medicine and engaged organizations like Choosing Wisely, Institute for Healthcare Improvement, and National Institute for Health and Care Excellence. Critics cited concerns about overuse of broad-spectrum antibiotics in contexts such as low- and middle-income countries and resource-limited hospitals exemplified by experiences in Médecins Sans Frontières programs, Partners In Health clinics, and referral centers in Sub-Saharan Africa and South Asia.

Impact and Outcomes

Multiple observational studies and quality reports from systems like Spanish Society of Intensive Care Medicine, Sociedade Brasileira de Terapia Intensiva, Japanese Association for Acute Medicine, Italian Society of Anesthesia Analgesia Resuscitation and Intensive Care, and German Interdisciplinary Association for Intensive Care and Emergency Medicine have documented changes in process measures, mortality trends, and cost patterns after Campaign adoption. Collaborations with registries and trials at University of California San Francisco, University of Melbourne, Peking Union Medical College Hospital, Seoul National University Hospital, and All India Institute of Medical Sciences contributed data used in meta-analyses published by editorial boards of Critical Care Medicine, Intensive Care Medicine, and Chest. Policy bodies including European Centre for Disease Prevention and Control and Pan American Health Organization have referenced Campaign materials in broader sepsis initiatives.

History and Evolution of the Campaign

The initiative traces its roots to meetings involving representatives from Society of Critical Care Medicine, European Society of Intensive Care Medicine, International Sepsis Forum, Eli Lilly and Company (early industry engagement), and philanthropic partners such as Gordon and Betty Moore Foundation and Wellcome Trust, followed by successive guideline updates, consensus conferences, and global implementation programs. Over time the Campaign has evolved in response to evidence generated by multicenter trials coordinated with entities like SMART trial investigators, LUNG SAFE study group, Sepsis-3 task force, Global Burden of Disease Study, and national audits from NHS England and Australian Commission on Safety and Quality in Health Care, adapting recommendations to emerging research and health system contexts.

Category:Sepsis